Pharmaceutical Technology

FEBRUARY 3, 2023

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.

Vaccine 293

Vaccine Vaccination Antibody Trials 293

World of DTC Marketing

NOVEMBER 10, 2020

You need to ask yourself why in the hell Pfizer’s CEO would say that their vaccine is 90% effective when there is a lot more testing and review of data needed. However, there’s still a long way to go before researchers can be certain that this vaccine is indeed as effective as promised. The media has not been helpful.

Vaccine 286

Vaccine Vaccination Marketing Drugs 286

Bio Pharma Dive

JANUARY 10, 2022

Pfizer's work with mRNA vaccines led it explore other applications of the technology, resulting in a multi-year partnership with the high-profile biotech Beam Therapeutics on gene editing treatments for rare diseases.

Gene Editing 363

Gene Editing Gene Research Vaccine 363

Bio Pharma Dive

AUGUST 11, 2020

The shot, developed by the state-backed Gamaleya Research Institute, hasn't yet been tested in the large, placebo-controlled tests scientists emphasize are needed to prove a vaccine is protective.

Vaccine 280

Vaccine Vaccination Scientist Development 280

Pharmaceutical Technology

DECEMBER 1, 2024

The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive treatment.

Vaccine 264

Vaccine Vaccination Manufacturing Drugs 264

Pharmaceutical Technology

AUGUST 17, 2022

On August 8, Pfizer and Valneva announced the initiation of a Phase III study with their Lyme disease vaccine , bringing the prospect of an injection to prevent the condition disease one step closer to reality. This means that the vaccine works against multiple serotypes of the disease, she explains. A one-size-fits-all approach.

Vaccine 299

Vaccine Vaccination Bacteria Protein 299

Pharmaceutical Technology

DECEMBER 22, 2023

As the number of patients with cancers continues to grow globally, research into personalised cancer vaccines is vital.

Vaccine 278

Vaccine Vaccination Research 278

Pharmaceutical Technology

JULY 1, 2022

Some months after the first Covid-19 vaccines became available, the World Health Organization (WHO) set a target of vaccinating 70% of each country’s population by the end of June 2022. The post Magazine-How delays derailed Covid-19 vaccination in Africa appeared first on Pharmaceutical Technology.

Vaccine 277

Vaccine Vaccination Big Data Development 277

Pharmaceutical Technology

NOVEMBER 26, 2024

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Vaccine 246

Vaccine Vaccination Clinical Research Research 246

Pharmaceutical Technology

APRIL 14, 2023

Ghana’s Food and Drug Authority (FDA) has approved R21/Matrix-M malaria vaccine in children aged 5 to 36 months, marking the first regulatory clearance for the University of Oxford-developed vaccine in any country in the world. Children between the ages of five and 36 months are at highest risk of death from malaria.

Vaccine 279

Vaccine Vaccination Manufacturing Containment 279

Bio Pharma Dive

JUNE 18, 2021

Compared to vaccines, development of antiviral drugs for the coronavirus has progressed more slowly, although data are expected soon from Merck, Pfizer and Atea.

Research 327

Research Vaccine Vaccination Development 327

Pharmaceutical Technology

OCTOBER 14, 2022

German pharmaceutical firm Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV). They subsequently expanded the collaboration to include the development of antigen mRNA cancer vaccines in 2018.

Vaccine 289

Vaccine Vaccination Development Immune Response 289

Bio Pharma Dive

JULY 9, 2024

The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals but also some notable setbacks during his time as Pfizer’s top scientist.

Scientist 304

Scientist Research Vaccine Vaccination 304

World of DTC Marketing

DECEMBER 11, 2020

(Mckinsey) Much of the prevailing market research on COVID-19 vaccination frames sentiment as “likely,” “unlikely,” or “neutral.” Their research has found that consumers’ attitudes towards receiving a COVID-19 vaccine fall into three primary segments.

Vaccine 227

Vaccine Vaccination Clinical Trials Clinical Trials 227

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 9, 2022

When babies in the African countries of Guinea Bissau and Uganda were given the tuberculosis vaccine, something remarkable happened. Skip advert Australian researchers […].

Vaccine 246

Vaccine Vaccination Bacteria Research 246

Bio Pharma Dive

SEPTEMBER 2, 2021

The pharma company is in a tight race with rivals, including GSK, to become the first with an approved shot for the infectious disease.

Pharma Companies 297

Pharma Companies Vaccination Vaccine Research 297

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. They intend to develop vaccines that provide lasting immune responses compared to existing vaccines.

Vaccine 245

Vaccine Vaccination Development RNA 245

Pharmaceutical Technology

NOVEMBER 25, 2022

XtalPi has entered a strategic partnership with CK Life Sciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). Under the collaboration, the companies will utilise their capabilities to co-develop a new AI tumour vaccine R&D platform.

Life Science 246

Life Science Vaccine Vaccination Development 246

Pharmaceutical Technology

JANUARY 13, 2023

The Biomedical Advanced Research and Development Authority (BARDA) has awarded a multi-year contract to the Sabin Vaccine Institute for developing and producing single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases. Currently, there are no licensed vaccines against these viruses.

Vaccine 246

Vaccine Vaccination Clinical Trials Clinical Trials 246

STAT News

SEPTEMBER 6, 2022

WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems getting existing vaccines to use in their research. Right now, Pfizer isn’t sharing its vaccines for research purposes, a spokesperson confirmed to STAT.

Vaccine 145

Vaccine Vaccination Research Production 145

World of DTC Marketing

AUGUST 26, 2021

The government has latitude to protect citizens from deadly conditions, especially when the science supporting vaccination is so clear” With respect to children, parents do not have carte blanche. The bottom line is that we have to take bolder steps to get everyone vaccinated because the unvaccinated represent a danger to us all.

Vaccine 222

Vaccine Vaccination Contamination Regulation 222

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The mRNA vaccine candidates will help reduce the chances of autoimmune responses that might lead to allergic conditions or serious autoimmune diseases.

Vaccine 245

Vaccine Vaccination Development Allergies 245

Pharmaceutical Technology

DECEMBER 5, 2022

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub.

Research 246

Research Gene Therapy Vaccine Vaccination 246

Rethinking Clinical Trials

AUGUST 22, 2023

In an article published this month in Clinical Trials , researchers from the NIH Pragmatic Trials Collaboratory’s Distributed Research Network share opportunities for conducting pragmatic trials embedded in health insurance plans. For more, see the Distributed Research Network page on the Living Textbook or read the full article.

Research 245

Research Clinical Trials Clinical Trials Trials 245

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccine 272

Vaccine Vaccination Sales Generic Drugs 272

Pharmaceutical Technology

JUNE 6, 2023

Oragenics has secured funding from the Canadian bioresearch consortium CQDM to develop a variant-agnostic protein antigen for use in its Covid-19 intranasal vaccine. The project is a partnership with Inspirevax and the National Research Council of Canada (NRC).

Vaccine 231

Vaccine Vaccination Development Manufacturing 231

Pharmaceutical Technology

JUNE 16, 2023

France-based biotech company Osivax has thrown its hat into the influenza ring by dosing the first subject with its vaccine candidate OVX836. The Phase IIa trial (NCT05734040) in Australia will see a potential 500 volunteers given OVX836 in combination with quadrivalent influenza vaccines (QIVs).

Vaccine 246

Vaccine Vaccination Trials Immune Response 246

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 3, 2023

An experimental vaccine that aims to slow down or prevent the progression of Alzheimer’s disease has been trialed in mice with promising early results. Mice engineered with genes that put them at greater risk of an Alzheimer’s-like disease had fewer amyloid plaques following the vaccine.

Vaccine 246

Vaccine Vaccination Engineer Gene 246

Bio Pharma Dive

MAY 10, 2023

The companies’ personalized shot generated tumor-specific T cells that researchers hope could help prevent pancreatic cancer from returning after surgery.

Vaccination 348

Vaccination Vaccine Research 348

Pharmaceutical Technology

NOVEMBER 1, 2022

What is Research and Development (R&D)? This category includes organisations that have demonstrated a commitment to the research and development of new products and/or new processes. This category highlights companies that have conducted research into the use of AI and technology for the development of new treatments.

Development 228

Development Research Production Vaccine 228

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 8, 2023

The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year.

Vaccine 246

Vaccine Vaccination Scientist Trials 246

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2024

Using viruses that infect bacteria to detect proteins sprouted by a notorious parasite, scientists have honed in on possible vaccine targets for schistosomiasis, a neglected tropical disease that currently affects an estimated 600 million people worldwide, causing 280,000 deaths per year.

Vaccine 240

Vaccine Vaccination Bacteria Protein 240

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 19, 2024

The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever phase 3 clinical trial for a dengue vaccine in India. The trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.

Clinical Trials 189

Clinical Trials Clinical Trials Vaccine Vaccination 189

Pharmaceutical Technology

OCTOBER 16, 2023

The US government's Covid-19 research programme has announced the vaccine candidates for its latest round of funding.

Vaccine 147

Vaccine Vaccination Research 147

Pharmaceutical Technology

DECEMBER 2, 2022

India’s Central Drugs Standard Control Organisation (CDSCO) has granted approval for Bharat Biotech’s BBV154 vaccine for treating Covid-19. BBV154 is claimed to be the first intra-nasal vaccine for Covid-19 in the world.

Vaccine 217

Vaccine Vaccination Clinical Trials Clinical Trials 217

Bio Pharma Dive

MAY 4, 2023

After issues with a contract research group, the partners now expect to file an approval application for their shot in 2026, one year later than initially anticipated.

Vaccination 315

Vaccination Vaccine Research 315

XTalks

NOVEMBER 12, 2024

November is Pancreatic Cancer Awareness Month , a time dedicated to increasing public understanding of this challenging disease, supporting patients and their families and advancing research for better treatment options. For this reason, researchers are working hard to find new methods to identify pancreatic cancer sooner.

Research 105

Research FDA Approval Trials Clinical Trials 105